Search DubaiPRNetwork.com

Home >> Healthcare & Medicine

Mundipharma set to provide innovative cold treatment for Adults and Children in new markets across the Middle East, Turkey and Africa region

Thursday, January 17, 2019/ Editor -  

Share

Home >> Healthcare & Medicine

Dubai, UAE, January 17, 2019:  Mundipharma, the maker of the BETADINETM range of products, announced expansion of the partnership with Marinomed Biotech to extend their rights for the Carragalose® based Nasal Sprays and Lozenges in additional markets across the Middle East, Turkey and Africa (META). 

The deal will aim to further extend marketing of Marinomed’s products which have shown to significantly reduce disease duration and reduce relapses and help more adults and children suffering from the symptoms of the disease in additional markets across the META region.

The common cold is a viral infection that affects adults twice per year on average. The impact is greater for children who can typically contract them up to five to seven times per year due to their exposure at school and the playground.

The new BETADINE™ COLD DEFENCE  is a natural product with anti-viral effects that helps reduce duration of colds in adults and children.1-4 It is delivered as a nasal spray and contains the ingredient iota-carrageenan, also called Carragelose®. It is available in adult and children’s formulations and is recommended for use at the first sign of cold symptoms.

Several large scale clinical trials involving close to 600 adult and pediatric patients were conducted to evaluate the efficacy and safety of the nasal spray. The analysis of children and adults suffering from virus-confirmed common cold after two randomized, double-blind, placebo-controlled trials the nasal spray appeared as an effective treatment of common cold.1-4

Ashraf Allam, Vice President of Mundipharma Middle East, Turkey & Africa said “Every year the common cold and flu negatively impact lives of the families. BETADINE™ COLD DEFENCE  will help adults and children1-4 overcome the early symptoms of cold and may prevent the progression of the disease.

“Making BETADINE™ COLD DEFENCE  range accessible in other countries across META region is a part of Mundipharma’s commitment of making the latest and most effective treatments available to our patients and help families lead a healthier, happier life” – he added.


Previous in Healthcare & Medicine

Next in Healthcare & Medicine


Home >> Healthcare & Medicine Section

Latest Press Release

The American Community School of Abu Dhabi Awards the Haitham Zamzam Al Hammadi ...

du Offers Seamless Telco Experience with UAE-First Linksys Training Initiative

61 percent of employees believe sustainability is mandatory for modern businesse ...

Longchamp & Kendall Jenner Celebrate the Launch of the Longchamp Lgp Collection ...

Embrace the Spirit of the Holy Month of Ramadan at Yas Mall, The Mall at World T ...

Seamless Customer Experience at Airports - Genetec

EEG Environemtnal Drawing Competition 2019

Jaguar Land Rover's Fiona Pargeter Recognised as Inaugural ‘woman of Worth' 2018

Jafza to Waive Aed 35 Million in Fines

Ramadan Promotion: 300% Bonus of the recharge value from Etisalat to share the s ...

Sharjah realty transactions hit AED5.2b in Q-1

Um Al Quwain Police and Pure Gold Jewellers unite prisoners with their families ...

Western Furniture announces Best Buy sale during Ramadan

Future Network Awards 2019 Awards Schneider Electric and NPCC under the category ...

The All-new Flying Spur: the Luxury Grand Touring Sedan

Travel Essentials Guide

New research from NYU Abu Dhabi discovers growing teleconnection between Atlanti ...

Marina Mall Abu Dhabi supports Make A Wish Foundation UAE with special Ramadan B ...

Salvatore Ferragamo Features Leather Sunglasses In the Spring/summer 2019 Adver ...

Michael Kors Co-hosts the 10th Anniversary of the Annual Filmmakers Dinner